AstraZeneca
AZN
#50
Rank
โ‚น27.477 T
Marketcap
โ‚น17,718
Share price
1.29%
Change (1 day)
48.21%
Change (1 year)

Revenue for AstraZeneca (AZN)

Revenue in 2026 (TTM): โ‚น5.409 Trillion

According to AstraZeneca's latest financial reports the company's current revenue (TTM ) is โ‚น5.822 Trillion. In 2025 the company made a revenue of โ‚น5.272 Trillion an increase over the revenue in the year 2024 that were of โ‚น4.638 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AstraZeneca from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น5.409 T2.59%
2025 โ‚น5.272 T13.67%
2024 โ‚น4.638 T21.63%
2023 โ‚น3.813 T3.92%
2022 โ‚น3.669 T31.78%
2021 โ‚น2.784 T43.07%
2020 โ‚น1.946 T11.95%
2019 โ‚น1.738 T12.58%
2018 โ‚น1.544 T7.68%
2017 โ‚น1.434 T-8.23%
2016 โ‚น1.563 T-4.8%
2015 โ‚น1.641 T-2.29%
2014 โ‚น1.680 T5.79%
2013 โ‚น1.588 T3.71%
2012 โ‚น1.531 T-13.81%
2011 โ‚น1.776 T19.2%
2010 โ‚น1.490 T-2.06%
2009 โ‚น1.522 T0.21%
2008 โ‚น1.518 T30.93%
2007 โ‚น1.160 T-1.07%
2006 โ‚น1.172 T8.8%
2005 โ‚น1.077 T16.15%
2004 โ‚น927.91 B8.12%
2003 โ‚น858.19 B1.42%
2002 โ‚น846.19 B-25.48%
2001 โ‚น1.135 T34.3%
2000 โ‚น845.50 B5.5%
1999 โ‚น801.46 B91.84%
1998 โ‚น417.78 B18.71%
1997 โ‚น351.94 B-14.33%
1996 โ‚น410.82 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.283 T 59.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.450 T-6.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น6.099 T 4.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น4.347 T-25.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น6.960 T 19.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น5.342 T-8.24%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น957.31 B-83.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.335 T 8.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.670 T-19.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น4.254 T-26.93%๐Ÿ‡ฌ๐Ÿ‡ง UK